A substance abuse screening, performed outdoors the purview of the Division of Transportation (DOT), analyzes organic samples for the presence of illicit substances and/or prescription medicines being misused. These panels typically embody, however usually are not restricted to, testing for substances resembling amphetamines, cannabinoids (THC), cocaine, opiates, and phencyclidine (PCP). Some expanded panels can also embody checks for benzodiazepines, barbiturates, methadone, and propoxyphene. The particular substances examined can range based mostly on the employer’s or group’s coverage and the chosen testing laboratory.
These screenings are helpful instruments for employers aiming to take care of a protected and productive work atmosphere, contributing to diminished office accidents and improved worker morale. Traditionally, the rise in substance abuse within the workforce has pushed the implementation of those screenings, mirroring societal considerations concerning drug use. The advantages lengthen past security and productiveness, encompassing potential reductions in healthcare prices and authorized liabilities related to drug-related incidents.